The proposed CTO's Outreach and Dissemination Unit will be led by Apostolia Maria Tsimberidou, M.D.,Ph.D., the proposed Director of Clinical Translation, Education and Outreach, under the guidance of Jason Sakamoto, Ph.D. the proposed CTO Center Manager. Dr. Tsimberidou is an Assistant Professor at MDACC, Department of Investigational Cancer Therapeutics, a Phase I Clinical Trials Program. Dr Sakamoto Is the Chief Operating Officer of the Alliance for NanoHealth (ANH). He will bring to these units his expertise and the already established infrastructure of ANH, including program management, website development and maintenance, pilot and training project development and outreach programs to assist the Outreach and Dissemination Unit. The Outreach and Dissemination Unit will implement initiatives to support the following aims: 1) Disseminate and increase awareness of concepts, capabilities, and results of PS-OC to physical sciences and cancer research communities;and 2) Provide a mechanism to bridge and develop external collaborations. The Outreach and Dissemination aims will be achieved via the following Initiatives: 1. Virtual seminars;2. Workshops with focus topic of Transport OncoPhysics;3. Virtual networking through Interactive websites;and 4. External Pilot projects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA143837-06
Application #
8564202
Study Section
Special Emphasis Panel (ZCA1-SRLB-9 (O1))
Project Start
2009-09-28
Project End
2015-07-31
Budget Start
2013-09-19
Budget End
2014-07-31
Support Year
6
Fiscal Year
2013
Total Cost
$198,749
Indirect Cost
$69,691
Name
Methodist Hospital Research Institute
Department
Type
DUNS #
185641052
City
Houston
State
TX
Country
United States
Zip Code
77030
Martinez, Jonathan O; Evangelopoulos, Michael; Bhavane, Rohan et al. (2015) Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs. Curr Drug Targets 16:1582-90
Corbo, Claudia; Parodi, Alessandro; Evangelopoulos, Michael et al. (2015) Proteomic Profiling of a Biomimetic Drug Delivery Platform. Curr Drug Targets 16:1540-7
Singh, Jaykrishna; Hussain, Fazle; Decuzzi, Paolo (2015) Role of differential adhesion in cell cluster evolution: from vasculogenesis to cancer metastasis. Comput Methods Biomech Biomed Engin 18:282-92
Wang, Zhihui; Butner, Joseph D; Kerketta, Romica et al. (2015) Simulating cancer growth with multiscale agent-based modeling. Semin Cancer Biol 30:70-8
Jaganathan, Hamsa; Mitra, Sucharita; Srinivasan, Srimeenakshi et al. (2014) Design and in vitro evaluation of layer by layer siRNA nanovectors targeting breast tumor initiating cells. PLoS One 9:e91986
Yang, Yong; Wolfram, Joy; Fang, Xiaohong et al. (2014) Polyarginine induces an antitumor immune response through binding to toll-like receptor 4. Small 10:1250-4
Koshkina, Nadezhda V; Briggs, Katrina; Palalon, Flavio et al. (2014) Autophagy and enhanced chemosensitivity in experimental pancreatic cancers induced by noninvasive radiofrequency field treatment. Cancer 120:480-91
Martinez, Jonathan O; Evangelopoulos, Michael; Karun, Vivek et al. (2014) The effect of multistage nanovector targeting of VEGFR2 positive tumor endothelia on cell adhesion and local payload accumulation. Biomaterials 35:9824-32
Gonzalez-Villasana, Vianey; Rodriguez-Aguayo, Cristian; Arumugam, Thiruvengadam et al. (2014) Bisphosphonates inhibit stellate cell activity and enhance antitumor effects of nanoparticle albumin-bound paclitaxel in pancreatic ductal adenocarcinoma. Mol Cancer Ther 13:2583-94
Koay, Eugene J; Truty, Mark J; Cristini, Vittorio et al. (2014) Transport properties of pancreatic cancer describe gemcitabine delivery and response. J Clin Invest 124:1525-36

Showing the most recent 10 out of 114 publications